- Home
- JPM vs LLY Comparison
JPM vs LLY Comparison
Compare JPM & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JPM
- LLY
- Stock Information
- Founded
- JPM 1799
- LLY 1876
- Country
- JPM United States
- LLY United States
- Employees
- JPM N/A
- LLY N/A
- Industry
- JPM Major Banks
- LLY Biotechnology: Pharmaceutical Preparations
- Sector
- JPM Finance
- LLY Health Care
- Exchange
- JPM Nasdaq
- LLY Nasdaq
- Market Cap
- JPM 826.4B
- LLY 666.0B
- IPO Year
- JPM N/A
- LLY N/A
- Fundamental
- Price
- JPM $309.10
- LLY $748.42
- Analyst Decision
- JPM Buy
- LLY Strong Buy
- Analyst Count
- JPM 14
- LLY 16
- Target Price
- JPM $308.15
- LLY $978.56
- AVG Volume (30 Days)
- JPM 7.0M
- LLY 3.5M
- Earning Date
- JPM 10-14-2025
- LLY 10-29-2025
- Dividend Yield
- JPM 1.81%
- LLY 0.80%
- EPS Growth
- JPM 8.70
- LLY 88.31
- EPS
- JPM 19.48
- LLY 15.29
- Revenue
- JPM $163,748,000,000.00
- LLY $53,258,100,000.00
- Revenue This Year
- JPM $8.97
- LLY $38.43
- Revenue Next Year
- JPM $2.69
- LLY $18.06
- P/E Ratio
- JPM $15.87
- LLY $48.92
- Revenue Growth
- JPM 1.71
- LLY 36.83
- 52 Week Low
- JPM $202.16
- LLY $623.78
- 52 Week High
- JPM $309.78
- LLY $939.86
- Technical
- Relative Strength Index (RSI)
- JPM 65.76
- LLY 55.49
- Support Level
- JPM $291.44
- LLY $719.22
- Resistance Level
- JPM $305.15
- LLY $761.60
- Average True Range (ATR)
- JPM 5.11
- LLY 14.97
- MACD
- JPM 0.84
- LLY 4.52
- Stochastic Oscillator
- JPM 95.46
- LLY 72.82
About JPM JP Morgan Chase & Co.
JPMorgan Chase is one of the largest and most complex financial institutions in the United States, with nearly $4 trillion in assets. It is organized into four major segments: consumer and community banking, corporate and investment banking, commercial banking, and asset and wealth management. JPMorgan operates, and is subject to regulation, in multiple countries.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.